ciprofloxacin has been researched along with Neutropenia in 157 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoroquinolones reduce occurrence of fever in adult cancer patients who develop neutropenia, but there has been no randomized controlled trial in children, and there are only a few studies considering resistance in intestinal floral after ciprofloxacin has been used." | 9.17 | Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. ( Chelae, S; Khwanna, T; Laoprasopwattana, K; Sujjanunt, T; Suwankeeree, P; Tunyapanit, W, 2013) |
| " The present study was designed to evaluate the benefit of intravenous ciprofloxacin for neutropenic patients with fever who were refractory to initial therapy given for the first 3 days." | 9.12 | Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy. ( Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K, 2006) |
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 9.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| "This intervention influenced administration of ciprofloxacin without apparent compromise of patient outcomes and resulted in a reduction in total costs of treating febrile neutropenia." | 9.09 | A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis. ( de Lemos, ML; Frighetto, L; Jewesson, PJ; Marra, CA; Marra, F; Quaia, CB; Warkentin, DI, 2000) |
| "Low-risk patients (N = 70) with episodes of fever and neutropenia (N = 116) were randomized to receive either oral ciprofloxacin or intravenous ceftriaxone as outpatients." | 9.09 | Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. ( Campos, MC; Dantas, LS; Ginani, VC; Petrilli, AS; Seber, A; Tanaka, C, 2000) |
| "We examined the efficacy of ciprofloxacin as an empirical treatment for fever in 97 neutropenic patients in a randomized study of ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin." | 9.06 | A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients. ( Jenkins, GC; Kelsey, SM; Newland, AC; Shaw, E; Wood, ME, 1990) |
| "This study developed further clinical experience in using a single agent ("monotherapy") as empirical treatment for neutropenic patients with fever, and compared the safety and toxicity of two candidate agents, ceftazidime and ciprofloxacin." | 9.06 | A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. ( Bayston, KF; Cohen, J; Want, S, 1989) |
| "To assess the efficacy of ciprofloxacin in neutropenic patients, we conducted a randomized prospective trial comparing the combination of ciprofloxacin and netilmicin against piperacillin plus netilmicin as an empiric treatment of fever in cancer patients with neutropenia." | 9.06 | Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. ( Anderson, H; Chan, CC; Oppenheim, BA; Scarffe, JH; Swindell, R, 1989) |
| "We compared the combination of teicoplanin plus ciprofloxacin with gentamicin plus piperacillin for the empirical treatment of fever in 80 neutropenic patients." | 9.06 | A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients. ( Collins, PW; Delord, C; Kelsey, SM; Newland, AC; Weinhard, B, 1990) |
| "To compare the effectiveness and toxicity of ciprofloxacin vs an aminoglycoside, both in combination with a beta-lactam, for the treatment of febrile neutropenia in the inpatient setting." | 8.82 | Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. ( Bliziotis, IA; Christodoulou, C; Chrysanthopoulou, S; Falagas, ME; Kasiakou, SK; Michalopoulos, A; Samonis, G, 2005) |
| "In this retrospective study, we analyzed the clinical data and outcome of patients with AML who did or did not receive prophylactic ciprofloxacin 500 mg BD for neutropenic fever." | 7.83 | Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy. ( Foratyazdi, M; Ghadiany, M; Mehdizadeh, M; Mohammad Alizadeh, A; Rahimi, H; Rezvani, H; Zamani, N, 2016) |
| "The objective of this investigation was to assess retrospectively the safety and the efficacy of oral ciprofloxacin plus cefuroxime axetil compared to the combination of oral ciprofloxacin plus amoxicillin/clavulanate, as initial outpatient treatment, in low-risk cancer patients with fever and neutropenia." | 7.74 | Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate. ( Karabelis, A; Kordossis, T; Kosmas, C; Sipsas, NV; Skopelitis, E; Tsavaris, N; Vadiaka, M; Ziakas, PD, 2007) |
| "The current results suggest that fluoroquinolone prophylaxis for patients with febrile neutropenia may be abandoned safely in areas with a high prevalence of ciprofloxacin-resistant enterobacteria." | 7.72 | Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. ( Dalmau, D; Estany, C; Estrada, C; Garau, J; Gomez, L; Marquez, M; Martí, JM; Xercavins, M, 2003) |
| "The current study demonstrates that very carefully selected, low risk patients with febrile neutropenia may be treated successfully without hospitalization using oral ciprofloxacin." | 7.70 | Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. ( Aquino, VM; Buchanan, GR; Herrera, L; Sandler, ES, 2000) |
| "Fifty consecutive episodes of neutropenia were studied in patients with AML who received prophylaxis with ciprofloxacin and these were compared with a historic control group of another 50 consecutive episodes of neutropenia in AML patients who did not receive antibiotic prophylaxis." | 7.69 | [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia]. ( Bueno, J; Juliá, A; López, A; Novo, A; Soler, JA, 1994) |
| "To assess the value of prophylactic ciprofloxacin in reducing the incidence of neutropenic fever in men receiving intensive chemotherapy for germ cell tumours, we reviewed the case notes of 88 consecutive patients treated between January 1986 and December 1992." | 7.69 | Chemotherapy for germ cell tumours: prophylactic ciprofloxacin reduces the incidence of neutropenic fever. ( Counsell, R; Pratt, J; Williams, MV, 1994) |
| "We studied the efficacy of piperacillin and ciprofloxacin as initial parenteral therapy in 41 adult patients with leukemia who developed 47 febrile episodes during severe neutropenia following chemotherapy." | 7.68 | A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients. ( Lerner, R; Nilsson, PG; Palmblad, J; Samuelsson, J; Wahlin, A; Winqvist, I, 1992) |
| "Inclusion criteria were cancer, febrile neutropenia, low risk of complications as predicted by a Multinational Association for Supportive Care in Cancer (MASCC) score > 20, ability to swallow, and ≤ one single intravenous dose of empiric antibiotic therapy before study drug treatment initiation." | 6.78 | Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectiou ( Akan, H; Akova, M; Aoun, M; Calandra, T; de Bock, R; Drgona, L; Kern, WV; Marchetti, O; Paesmans, M; Viscoli, C, 2013) |
| "Patients with stage T2-T4 primary breast cancer were scheduled to receive 6-8 cycles of TAC." | 6.73 | Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. ( Costa, SD; du Bois, A; Eidtmann, H; Eiermann, W; Gerber, B; Grasshoff, ST; Hilfrich, J; Huober, J; Jackisch, C; Kaufmann, M; Kümmel, S; Loibl, S; Mehta, KM; Skacel, T; Vescia, S; von Minckwitz, G, 2008) |
| "Pediatric cancer patients presenting with febrile neutropenia after non-myeloablative chemotherapy and who met institutional criteria for early hospital discharge following a minimum of 48-hr inpatient empiric intravenous ceftazidime were eligible for the study." | 6.71 | Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. ( Burns, JL; Coughlin, J; Friedman, DL; Hawkins, D; Park, JR; Pendergrass, T, 2003) |
| "Ciprofloxacin was compared to ciprofloxacin plus amoxicillin as antibacterial prophylaxis in 53 evaluable patients with neutropenic episodes, because an oral penicillin may help to decrease the incidence of gram-positive infections." | 6.67 | Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin. ( Bosi, A; Ciolli, S; Donnini, E; Fanci, R; Guidi, S; Leoni, F; Longo, G; Rossi Ferrini, P, 1993) |
| "In a randomized study comparing cotrimoxazole plus colistin with ciprofloxacin, each in combination with nonabsorbable antimycotics, the incidence of major infections in terms of septicemias and pneumonias as well as of minor infections and episodes of unexplained fever (FUO) was higher in patients treated with ciprofloxacin." | 6.16 | Prevention of infection in acute leukemia. ( Daenen, S; de Pauw, BE; de Vries-Hospers, HG; Dekker, AW; Donnelly, JP; Gaus, W; Haralambie, E; Kern, W; Konrad, H; Maschmeyer, G, 1990) |
| "Bacteremia was documented in 33 patients (15." | 5.46 | Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis. ( Anurathapan, U; Choeyprasert, W; Hongeng, S; Pakakasama, S, 2017) |
| " Serious adverse reactions reported with ciprofloxacin are rare with an incidence of 0." | 5.35 | Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin. ( Ruxana, K; Upadya, GM, 2009) |
| "Unfortunately, neutropenia is common." | 5.31 | The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization. ( Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K, 2002) |
| "Fluoroquinolones reduce occurrence of fever in adult cancer patients who develop neutropenia, but there has been no randomized controlled trial in children, and there are only a few studies considering resistance in intestinal floral after ciprofloxacin has been used." | 5.17 | Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. ( Chelae, S; Khwanna, T; Laoprasopwattana, K; Sujjanunt, T; Suwankeeree, P; Tunyapanit, W, 2013) |
| "Ciprofloxacin (CPFX) is a potential alternative in patients with febrile neutropenia (FN) because of its activity against Gram-negative organisms." | 5.17 | Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies. ( Atsuta, Y; Emi, N; Inamoto, Y; Ishikawa, Y; Nagai, H; Naoe, T; Ozawa, Y; Ozeki, K; Suzuki, R; Terakura, S; Yanada, M; Yasuda, T, 2013) |
| " After a pre-intervention period, in which cefepime was used as the initial agent for febrile neutropenia, 4 primary antibiotics, namely, piperacillin-tazobactam, ciprofloxacin, meropenem, and cefepime, were rotated at 1-month intervals over 20 months." | 5.17 | Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. ( Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H, 2013) |
| " The present study was designed to evaluate the benefit of intravenous ciprofloxacin for neutropenic patients with fever who were refractory to initial therapy given for the first 3 days." | 5.12 | Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy. ( Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K, 2006) |
| "An open-label randomised clinical trial was designed to compare the efficacy and tolerance of levofloxacin and ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with high-risk neutropenia, and to monitor the emergence of antimicrobial resistance." | 5.12 | Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies. ( Huijgens, PC; Janssen, JJ; Leidekker, ME; Simoons-Smit, AM; Timmers, GJ; Vandenbroucke-Grauls, CM, 2007) |
| "To determine whether ciprofloxacin-piperacillin is equivalent to tobramycin-piperacillin as empirical therapy for neutropenic fever." | 5.10 | Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial. ( Cushing, DA; Donowitz, GR; Harman, CP; Haverstock, DC; Herrington, DA; Hurd, DD; Kowalsky, SF; Lazarus, HM; Peacock, JE; Reed, MD; Sinclair, JW; Wade, JC, 2002) |
| "Evaluation of benzylpenicillin (penicillin G) effect for infection prophylaxis at the oncological patients with severe postcytostatic neutropenia was performed." | 5.10 | [Benzylpenicillin efficacy for neutropenic infection prophylaxis in patients with cancer and postcytostatic neutropenia]. ( Chimishkian, KL; Dmitrieva, NV; Larionova, VB; Minenko, SV; Ptushkin, VV; Sokolova, EN; Zhukov, NV, 2002) |
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 5.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| "This intervention influenced administration of ciprofloxacin without apparent compromise of patient outcomes and resulted in a reduction in total costs of treating febrile neutropenia." | 5.09 | A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis. ( de Lemos, ML; Frighetto, L; Jewesson, PJ; Marra, CA; Marra, F; Quaia, CB; Warkentin, DI, 2000) |
| "To determine whether the addition of rifampin to a quinolone-based antibacterial prophylactic regimen in patients undergoing high-dose chemotherapy (HDC) with peripheral-blood stem-cell transplantation (PBSCT) decreases the incidence of neutropenia and fever, Gram-positive bacteremia, and infection-related morbidity." | 5.09 | Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial. ( Arcediano, A; Cortés-Funes, H; Gomez-Martin, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Rodriguez, M; Salazar, R; Solá, C; Valentí, V, 2000) |
| "In hospitalized low-risk patients who have fever and neutropenia during cancer chemotherapy, empirical therapy with oral ciprofloxacin and amoxicillin-clavulanate is safe and effective." | 5.09 | A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. ( Chanock, S; Freifeld, A; Gill, V; Hicks, JE; Hiemenz, J; Hiemenz, S; Lewis, L; Marchigiani, D; Pizzo, PA; Steinberg, SM; Walsh, T, 1999) |
| "Low-risk patients (N = 70) with episodes of fever and neutropenia (N = 116) were randomized to receive either oral ciprofloxacin or intravenous ceftriaxone as outpatients." | 5.09 | Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. ( Campos, MC; Dantas, LS; Ginani, VC; Petrilli, AS; Seber, A; Tanaka, C, 2000) |
| "The objective of this study was to evaluate the efficacy of oral ciprofloxacin in preventing febrile morbidity superimposed on the neutropenia induced from a paclitaxel regimen in ovarian cancer patients." | 5.08 | Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial. ( Carlson, JW; Carson, LF; Copeland, LJ; Fowler, JM; Mayer, AR; Mitchell, SK, 1997) |
| "The purpose of this study was to test the comparative efficacy and toxicity of empiric gentamicin and ciprofloxacin, in combination with piperacillin, in febrile patients with treatment-induced neutropenia." | 5.08 | Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy. ( Betts, RF; Blair, EA; Flesher, WR; Griggs, JJ; Norton, JR; Rowe, JM, 1998) |
| "More patients receiving ciprofloxacin did not develop fever during neutropenia and did not receive antibiotics (34%) compared with those receiving norfloxacin (25%) (P = 0." | 5.07 | Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. ( , 1991) |
| "Teicoplanin plus ciprofloxacin was compared with gentamicin plus piperacillin for the empirical treatment of fever in 80 neutropenic patients." | 5.07 | Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients. ( Collins, PW; Kelsey, SM; Newland, AC; Weinhardt, B, 1992) |
| "We studied the effectiveness of prophylactic oral ciprofloxacin and rifampin on fever prevention in patients undergoing autologous bone marrow transplantation (ABMT) for breast cancer." | 5.07 | Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. ( Gilbert, C; Hussein, A; Meisenberg, B; Perfect, J; Peters, WP; Ross, M; Vredenburgh, J, 1994) |
| "This study developed further clinical experience in using a single agent ("monotherapy") as empirical treatment for neutropenic patients with fever, and compared the safety and toxicity of two candidate agents, ceftazidime and ciprofloxacin." | 5.06 | A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. ( Bayston, KF; Cohen, J; Want, S, 1989) |
| "To assess the efficacy of ciprofloxacin in neutropenic patients, we conducted a randomized prospective trial comparing the combination of ciprofloxacin and netilmicin against piperacillin plus netilmicin as an empiric treatment of fever in cancer patients with neutropenia." | 5.06 | Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. ( Anderson, H; Chan, CC; Oppenheim, BA; Scarffe, JH; Swindell, R, 1989) |
| "We examined the efficacy of ciprofloxacin as an empirical treatment for fever in 97 neutropenic patients in a randomized study of ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin." | 5.06 | A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients. ( Jenkins, GC; Kelsey, SM; Newland, AC; Shaw, E; Wood, ME, 1990) |
| "We compared the combination of teicoplanin plus ciprofloxacin with gentamicin plus piperacillin for the empirical treatment of fever in 80 neutropenic patients." | 5.06 | A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients. ( Collins, PW; Delord, C; Kelsey, SM; Newland, AC; Weinhard, B, 1990) |
| "In a multicenter, randomized clinical trial, the efficacy of ciprofloxacin plus azlocillin was compared with that of a standard regimen of ceftazidime plus amikacin for the initial empiric treatment of fever in neutropenic cancer patients." | 5.06 | Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. ( Arnow, P; Edlin, B; Flaherty, JP; George, D; O'Keefe, P; Waitley, D; Weinstein, RA, 1989) |
| "To compare the effectiveness and toxicity of ciprofloxacin vs an aminoglycoside, both in combination with a beta-lactam, for the treatment of febrile neutropenia in the inpatient setting." | 4.82 | Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. ( Bliziotis, IA; Christodoulou, C; Chrysanthopoulou, S; Falagas, ME; Kasiakou, SK; Michalopoulos, A; Samonis, G, 2005) |
| "A retrospective chart review was completed comparing the use of prophylactic moxifloxacin to that of levofloxacin or ciprofloxacin during periods of prolonged neutropenia." | 3.85 | Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy. ( Przybylski, DJ; Reeves, DJ, 2017) |
| "In this retrospective study, we analyzed the clinical data and outcome of patients with AML who did or did not receive prophylactic ciprofloxacin 500 mg BD for neutropenic fever." | 3.83 | Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy. ( Foratyazdi, M; Ghadiany, M; Mehdizadeh, M; Mohammad Alizadeh, A; Rahimi, H; Rezvani, H; Zamani, N, 2016) |
| "We analyzed a cohort of 329 episodes of chemotherapy-induced neutropenia in adults, and compared two periods: 2005 (period 1, no prophylaxis, n=110) and 2006-2008 (period 2, ciprofloxacin prophylaxis, n=219)." | 3.79 | Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance. ( Garnica, M; Maiolino, A; Moreira, BM; Nouér, SA; Nucci, M; Pellegrino, FL, 2013) |
| "This study seeks to determine the incidence of vancomycin-resistant enterococci (VRE) infection in high-risk neutropenic fever patients colonized with VRE and to determine patient characteristics associated with VRE infection." | 3.76 | Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. ( Bossaer, JB; Garrett-Mayer, E; Hall, PD, 2010) |
| "The study confirms that oral ciprofloxacin and amoxicillin - clavulanate is a valuable alternative to the parenteral treatment combination in the management of NHL patients with chemotherapy-induced low risk febrile neutropenia." | 3.76 | [Oral antibiotics for non-Hodgkin's lymphoma patients with low risk neutropenic fever--a comparative controlled study]. ( Elis, A; Lishner, M; Manor, Y; Shacham-Abulafia, A, 2010) |
| " Neutropenia and thrombocytopenia associated with cefoxitin developed in 33 (51%) and 4 (6%) patients, respectively." | 3.75 | Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. ( Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK, 2009) |
| "The objective of this investigation was to assess retrospectively the safety and the efficacy of oral ciprofloxacin plus cefuroxime axetil compared to the combination of oral ciprofloxacin plus amoxicillin/clavulanate, as initial outpatient treatment, in low-risk cancer patients with fever and neutropenia." | 3.74 | Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate. ( Karabelis, A; Kordossis, T; Kosmas, C; Sipsas, NV; Skopelitis, E; Tsavaris, N; Vadiaka, M; Ziakas, PD, 2007) |
| "Of the 60 consecutive patients who received neoadjuvant chemotherapy as a phase II trial of docetaxel (60 mg/m(2)) and doxorubicin (50 mg/m(2)) for primary breast cancer, 30 low-risk febrile patients received oral ciprofloxacin." | 3.74 | The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone. ( Ando, M; Katsumata, N; Mizuno, T; Mukai, H; Shimizu, C; Watanabe, T, 2007) |
| "The current results suggest that fluoroquinolone prophylaxis for patients with febrile neutropenia may be abandoned safely in areas with a high prevalence of ciprofloxacin-resistant enterobacteria." | 3.72 | Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. ( Dalmau, D; Estany, C; Estrada, C; Garau, J; Gomez, L; Marquez, M; Martí, JM; Xercavins, M, 2003) |
| "The current study demonstrates that very carefully selected, low risk patients with febrile neutropenia may be treated successfully without hospitalization using oral ciprofloxacin." | 3.70 | Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. ( Aquino, VM; Buchanan, GR; Herrera, L; Sandler, ES, 2000) |
| " We evaluated retrospectively the effect of antibiotic prophylaxis with ciprofloxacin and penicillin on the prevention of bacterial infections in 112 cases of prolonged neutropenia in adult patients treated for haematological malignancies." | 3.70 | [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]. ( Baumgartner, JD; Cometta, A; Delarive, P; Glauser, MP, 2000) |
| "To assess the value of prophylactic ciprofloxacin in reducing the incidence of neutropenic fever in men receiving intensive chemotherapy for germ cell tumours, we reviewed the case notes of 88 consecutive patients treated between January 1986 and December 1992." | 3.69 | Chemotherapy for germ cell tumours: prophylactic ciprofloxacin reduces the incidence of neutropenic fever. ( Counsell, R; Pratt, J; Williams, MV, 1994) |
| "Fifty consecutive episodes of neutropenia were studied in patients with AML who received prophylaxis with ciprofloxacin and these were compared with a historic control group of another 50 consecutive episodes of neutropenia in AML patients who did not receive antibiotic prophylaxis." | 3.69 | [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia]. ( Bueno, J; Juliá, A; López, A; Novo, A; Soler, JA, 1994) |
| "The objective of this study was to determine the efficacy and safety of the combination ciprofloxacin plus amoxicillin/clavulanic acid as an empirical treatment of infection in hematologic patients without severe neutropenia." | 3.69 | Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients. ( Caballero, MD; Cañizo, MC; Colino, CI; Galende, J; García-Sanz, R; Gil-Hurlé, A; Hernández, JM; San Miguel, JF; Vallejo, C; Vázquez, L, 1997) |
| "We studied the efficacy of piperacillin and ciprofloxacin as initial parenteral therapy in 41 adult patients with leukemia who developed 47 febrile episodes during severe neutropenia following chemotherapy." | 3.68 | A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients. ( Lerner, R; Nilsson, PG; Palmblad, J; Samuelsson, J; Wahlin, A; Winqvist, I, 1992) |
| "Twenty-four episodes of fever in neutropenic patients with haematological malignancy were treated with ciprofloxacin." | 3.67 | Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1986) |
| "Forty-six episodes of fever in 34 patients with neutropenia and haematological malignancy were treated empirically with a combination of ciprofloxacin and vancomycin." | 3.67 | A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1988) |
| "Inclusion criteria were cancer, febrile neutropenia, low risk of complications as predicted by a Multinational Association for Supportive Care in Cancer (MASCC) score > 20, ability to swallow, and ≤ one single intravenous dose of empiric antibiotic therapy before study drug treatment initiation." | 2.78 | Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectiou ( Akan, H; Akova, M; Aoun, M; Calandra, T; de Bock, R; Drgona, L; Kern, WV; Marchetti, O; Paesmans, M; Viscoli, C, 2013) |
| "The standard treatment of fever in chemotherapy-induced neutropenia (FN) includes emergency hospitalization and empirical intravenous antimicrobial therapy." | 2.77 | First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study. ( Ammann, RA; Bodmer, N; Brack, E; Kühne, T; Leibundgut, K; Niggli, FK; Simon, A, 2012) |
| "Patients with stage T2-T4 primary breast cancer were scheduled to receive 6-8 cycles of TAC." | 2.73 | Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. ( Costa, SD; du Bois, A; Eidtmann, H; Eiermann, W; Gerber, B; Grasshoff, ST; Hilfrich, J; Huober, J; Jackisch, C; Kaufmann, M; Kümmel, S; Loibl, S; Mehta, KM; Skacel, T; Vescia, S; von Minckwitz, G, 2008) |
| " Daily assessments were made of all patients and all adverse events were recorded." | 2.73 | A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients. ( Giannakakis, T; Hatzitolios, A; Kollaras, P; Kordosis, T; Metallidis, S; Nikolaidis, J; Nikolaidis, P; Seitanidis, B, 2008) |
| "We treated low-risk febrile neutropenic cancer patients utilizing two standard outpatient antibiotic pathways: oral ampicillin/clavulanate (500 mg) and ciprofloxacin (500 mg) or intravenous ceftazidime (2 g) and clindamycin (600 mg) every 8 h." | 2.71 | Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients. ( Badrina, N; Benjamin, R; DeJesus, Y; Escalante, CP; Fernandez, S; Ho, V; Lam, T; Lee, EL; Manzullo, E; Rivera, E; Rolston, K; Valdres, R; Weiser, MA, 2004) |
| "Neutropenic fever is one of the most serious adverse effects of cancer chemotherapy." | 2.71 | Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer. ( Goto, K; Kakinuma, R; Kubota, K; Matsumoto, T; Niho, S; Nishiwaki, Y; Ohe, Y; Ohmatsu, H, 2004) |
| "Pediatric cancer patients presenting with febrile neutropenia after non-myeloablative chemotherapy and who met institutional criteria for early hospital discharge following a minimum of 48-hr inpatient empiric intravenous ceftazidime were eligible for the study." | 2.71 | Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. ( Burns, JL; Coughlin, J; Friedman, DL; Hawkins, D; Park, JR; Pendergrass, T, 2003) |
| "Only two Gram-negative bacterial infections occurred in the CIP + COL arm compared with 16 in the NEO + COL arm." | 2.70 | Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance. ( Bhamra, A; Hann, IM; Kibbler, CC; Nazareth, B; Paterson, P; Prentice, HG, 2001) |
| "Ciprofloxacin was therefore superior to the other two fluoroquinolones in preventing infections due to Gram-negative bacteria in this population of neutropenic patients." | 2.67 | Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. ( Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Favalli, C; Fioritoni, G; Iacone, A; Parruti, G; Piccolomini, R; Quaglietta, AM, 1994) |
| "Ciprofloxacin was associated with a low incidence of adverse events with skin rash (five cases) and nausea (one case) being reported as possibly or probably related to ciprofloxacin." | 2.67 | High dose intravenous ciprofloxacin in febrile neutropenic patients. ( Johnson, PR; Tooth, JA; Yin, JA, 1990) |
| "There were five superinfections, all in the gentamicin/azlocillin group." | 2.67 | Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients. ( Barker, KF; Kaczmarski, RS; Mufti, GJ; Philpott-Howard, JN; Smedley, JC; Wade, JJ, 1990) |
| "Ciprofloxacin was compared to ciprofloxacin plus amoxicillin as antibacterial prophylaxis in 53 evaluable patients with neutropenic episodes, because an oral penicillin may help to decrease the incidence of gram-positive infections." | 2.67 | Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin. ( Bosi, A; Ciolli, S; Donnini, E; Fanci, R; Guidi, S; Leoni, F; Longo, G; Rossi Ferrini, P, 1993) |
| "Thus, up to date management of cancer patients, in addition to other supportive care modalities, should also incorporate diagnostic methods and therapy of infections." | 2.47 | [Treatment and prevention of infections in cancer patients with neutropenia]. ( Sinkó, J, 2011) |
| "Patients who are treated for acute leukemia should be offered prophylaxis with ciprofloxacin or levofloxacin." | 2.43 | Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions. ( Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M, 2006) |
| "Allergic interstitial nephritis is believed to be the underlying pathological-process." | 2.38 | Ciprofloxacin-induced nephrotoxicity in patients with cancer. ( Bodey, GP; Lo, WK; Rolston, KV; Rubenstein, EB, 1993) |
| "Bacteremia was documented in 33 patients (15." | 1.46 | Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis. ( Anurathapan, U; Choeyprasert, W; Hongeng, S; Pakakasama, S, 2017) |
| "Treatment with voriconazole was promptly started with success." | 1.43 | Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia. ( Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M, 2016) |
| " One equivalent generic was selected for analysis by high-pressure liquid chromatography-tandem mass spectrometry (LC-MS/MS), to confirm chemical identity, and resistance selection experiments in a hollow-fiber (HF) system simulating two clinical dosing regimens." | 1.42 | Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin. ( Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF, 2015) |
| " Serious adverse reactions reported with ciprofloxacin are rare with an incidence of 0." | 1.35 | Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin. ( Ruxana, K; Upadya, GM, 2009) |
| "Ciprofloxacin (CIP) was the least active agent tested (MIC90 4 microg/ml; 86% susceptible)." | 1.31 | Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection. ( Jones, RN; Mutnick, AH; Turner, PJ, 2002) |
| "Unfortunately, neutropenia is common." | 1.31 | The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization. ( Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K, 2002) |
| "Levofloxacin was somewhat more active against methicillin-resistant Staphylococcus aureus isolates." | 1.31 | Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. ( Catamo, G; D'Antonio, D; D'Ercole, S; Di Bonaventura, G; Piccolomini, R, 2002) |
| " Rats were also treated with E5 or B55 in combination with a suboptimal dose of ciprofloxacin at fever onset and again 24 h later." | 1.29 | Efficacy of anti-endotoxin monoclonal antibody E5 alone or in combination with ciprofloxacin in neutropenic rats with Pseudomonas sepsis. ( Opal, SM; Palardy, JE; Romulo, RL, 1993) |
| "Neutropenia was less severe (P < 0." | 1.29 | Prevention of bacteraemia by systemic ciprofloxacin treatment in rat cytomegalovirus-infected immunocompromised rats. ( Bruggeman, CA; Stals, FS; vd Bogaard, AE, 1994) |
| "Fleroxacin was inactive against S." | 1.28 | In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin. ( Beskid, G; Chan, K; Cleeland, R; Keith, DD; McGarry, CM; Siebelist, J, 1990) |
| "In ciprofloxacin-treated patients the flora were almost completely ciprofloxacin-resistant, whereas in the control groups resistant flora were detected only occasionally." | 1.28 | Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. ( Huovinen, P; Kotilainen, P; Nikoskelainen, J, 1990) |
| "Ciprofloxacin was withdrawn from use in the unit and daily bathing with chlorhexidine gluconate solution started." | 1.28 | Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit. ( Burnie, JP; Hartley, JW; Lee, W; Oppenheim, BA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (11.46) | 18.7374 |
| 1990's | 61 (38.85) | 18.2507 |
| 2000's | 52 (33.12) | 29.6817 |
| 2010's | 25 (15.92) | 24.3611 |
| 2020's | 1 (0.64) | 2.80 |
| Authors | Studies |
|---|---|
| Forde, C | 1 |
| McMullan, R | 1 |
| Clarke, M | 1 |
| Wilson, RH | 1 |
| Plummer, R | 1 |
| Grayson, M | 1 |
| McDowell, C | 1 |
| Agus, A | 1 |
| Doran, A | 1 |
| McAuley, DF | 1 |
| Thomas, AL | 1 |
| Barnes, RA | 1 |
| Adams, R | 1 |
| Chau, I | 1 |
| Coyle, V | 1 |
| Przybylski, DJ | 1 |
| Reeves, DJ | 1 |
| Wattier, RL | 1 |
| Levy, ER | 1 |
| Sabnis, AJ | 1 |
| Dvorak, CC | 1 |
| Auerbach, AD | 1 |
| Castagnola, E | 1 |
| Moroni, C | 1 |
| Bandettini, R | 1 |
| Caprino, D | 1 |
| Haupt, R | 1 |
| Garnica, M | 1 |
| Nouér, SA | 1 |
| Pellegrino, FL | 1 |
| Moreira, BM | 1 |
| Maiolino, A | 1 |
| Nucci, M | 2 |
| De Rosa, FG | 1 |
| Motta, I | 1 |
| Audisio, E | 1 |
| Frairia, C | 1 |
| Busca, A | 1 |
| Di Perri, G | 1 |
| Marmont, F | 1 |
| Ghadiany, M | 1 |
| Rahimi, H | 1 |
| Rezvani, H | 1 |
| Mohammad Alizadeh, A | 1 |
| Zamani, N | 1 |
| Mehdizadeh, M | 1 |
| Foratyazdi, M | 1 |
| Blennow, O | 1 |
| Ljungman, P | 1 |
| Sparrelid, E | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Rodriguez, CA | 1 |
| Agudelo, M | 1 |
| Zuluaga, AF | 1 |
| Vesga, O | 1 |
| Mayer, K | 1 |
| Hahn-Ast, C | 1 |
| Mückter, S | 1 |
| Schmitz, A | 1 |
| Krause, S | 1 |
| Felder, L | 1 |
| Bekeredjian-Ding, I | 1 |
| Molitor, E | 1 |
| Brossart, P | 1 |
| von Lilienfeld-Toal, M | 1 |
| Petru, E | 1 |
| Singer, CF | 1 |
| Polterauer, S | 1 |
| Galid, A | 1 |
| Schauer, C | 1 |
| Klocker, J | 1 |
| Seifert, M | 1 |
| Reinthaller, A | 1 |
| Benedicic, C | 1 |
| Hubalek, M | 1 |
| Hefler, L | 1 |
| Marth, C | 1 |
| Scholl-Firon, T | 1 |
| Bogner, G | 1 |
| Zeimet, AG | 1 |
| Decembrino, N | 1 |
| Zecca, M | 1 |
| Tortorano, AM | 1 |
| Mangione, F | 1 |
| Lallitto, F | 1 |
| Introzzi, F | 1 |
| Bergami, E | 1 |
| Marone, P | 1 |
| Tamarozzi, F | 1 |
| Cavanna, C | 1 |
| Flinn, A | 1 |
| McDermott, M | 1 |
| Butler, KM | 1 |
| Pohlen, M | 1 |
| Marx, J | 1 |
| Mellmann, A | 1 |
| Becker, K | 1 |
| Mesters, RM | 1 |
| Mikesch, JH | 1 |
| Schliemann, C | 1 |
| Lenz, G | 1 |
| Müller-Tidow, C | 1 |
| Büchner, T | 1 |
| Krug, U | 1 |
| Stelljes, M | 1 |
| Karch, H | 1 |
| Peters, G | 2 |
| Gerth, HU | 1 |
| Görlich, D | 1 |
| Berdel, WE | 1 |
| Choeyprasert, W | 1 |
| Hongeng, S | 1 |
| Anurathapan, U | 1 |
| Pakakasama, S | 1 |
| Metallidis, S | 1 |
| Kollaras, P | 1 |
| Giannakakis, T | 1 |
| Seitanidis, B | 1 |
| Kordosis, T | 1 |
| Nikolaidis, J | 1 |
| Hatzitolios, A | 1 |
| Nikolaidis, P | 1 |
| Jeon, K | 1 |
| Kwon, OJ | 1 |
| Lee, NY | 1 |
| Kim, BJ | 1 |
| Kook, YH | 1 |
| Lee, SH | 1 |
| Park, YK | 1 |
| Kim, CK | 1 |
| Koh, WJ | 1 |
| Kitada, N | 1 |
| Nishino, M | 1 |
| Yasuda, J | 1 |
| Morita, S | 1 |
| Fujii, C | 1 |
| Minegaki, T | 1 |
| Kondoh, M | 1 |
| Anami, S | 1 |
| Takara, K | 1 |
| Watari, M | 1 |
| Upadya, GM | 1 |
| Ruxana, K | 1 |
| Bossaer, JB | 1 |
| Hall, PD | 1 |
| Garrett-Mayer, E | 1 |
| Eleutherakis-Papaiakovou, E | 1 |
| Kostis, E | 1 |
| Migkou, M | 1 |
| Christoulas, D | 1 |
| Terpos, E | 1 |
| Gavriatopoulou, M | 1 |
| Roussou, M | 1 |
| Bournakis, E | 1 |
| Kastritis, E | 1 |
| Efstathiou, E | 1 |
| Dimopoulos, MA | 1 |
| Papadimitriou, CA | 1 |
| Shacham-Abulafia, A | 1 |
| Elis, A | 1 |
| Manor, Y | 1 |
| Lishner, M | 1 |
| Sinkó, J | 1 |
| Brack, E | 1 |
| Bodmer, N | 1 |
| Simon, A | 1 |
| Leibundgut, K | 1 |
| Kühne, T | 1 |
| Niggli, FK | 1 |
| Ammann, RA | 2 |
| Mullen, CA | 3 |
| Laoprasopwattana, K | 1 |
| Khwanna, T | 1 |
| Suwankeeree, P | 1 |
| Sujjanunt, T | 1 |
| Tunyapanit, W | 1 |
| Chelae, S | 1 |
| Yasuda, T | 1 |
| Suzuki, R | 1 |
| Ishikawa, Y | 1 |
| Terakura, S | 1 |
| Inamoto, Y | 1 |
| Yanada, M | 1 |
| Nagai, H | 1 |
| Ozawa, Y | 1 |
| Ozeki, K | 1 |
| Atsuta, Y | 1 |
| Emi, N | 1 |
| Naoe, T | 1 |
| Slavin, MA | 1 |
| Thursky, KA | 1 |
| Kern, WV | 2 |
| Marchetti, O | 1 |
| Drgona, L | 1 |
| Akan, H | 1 |
| Aoun, M | 2 |
| Akova, M | 1 |
| de Bock, R | 1 |
| Paesmans, M | 2 |
| Viscoli, C | 1 |
| Calandra, T | 1 |
| Chong, Y | 1 |
| Shimoda, S | 1 |
| Yakushiji, H | 1 |
| Ito, Y | 1 |
| Miyamoto, T | 1 |
| Kamimura, T | 1 |
| Shimono, N | 1 |
| Akashi, K | 1 |
| Peacock, JE | 1 |
| Herrington, DA | 1 |
| Wade, JC | 1 |
| Lazarus, HM | 1 |
| Reed, MD | 1 |
| Sinclair, JW | 1 |
| Haverstock, DC | 1 |
| Kowalsky, SF | 1 |
| Hurd, DD | 1 |
| Cushing, DA | 1 |
| Harman, CP | 1 |
| Donowitz, GR | 1 |
| Mutnick, AH | 1 |
| Turner, PJ | 1 |
| Jones, RN | 1 |
| Di Bonaventura, G | 1 |
| D'Antonio, D | 5 |
| Catamo, G | 1 |
| D'Ercole, S | 1 |
| Piccolomini, R | 3 |
| Avery, RK | 1 |
| Pohlman, BL | 1 |
| Mossad, SB | 1 |
| Goormastic, M | 1 |
| Longworth, DL | 1 |
| Kalaycio, ME | 1 |
| Sobecks, RM | 1 |
| Andresen, SW | 1 |
| Kuczkowski, E | 1 |
| Bernhard, L | 1 |
| Ostendorf, H | 1 |
| Wise, K | 1 |
| Bolwell, BJ | 1 |
| Park, JR | 1 |
| Coughlin, J | 1 |
| Hawkins, D | 1 |
| Friedman, DL | 1 |
| Burns, JL | 1 |
| Pendergrass, T | 1 |
| Zomorrodi, A | 1 |
| Wald, ER | 1 |
| Gowda, RV | 1 |
| Stout, R | 1 |
| Minenko, SV | 1 |
| Dmitrieva, NV | 1 |
| Chimishkian, KL | 1 |
| Zhukov, NV | 1 |
| Sokolova, EN | 1 |
| Larionova, VB | 1 |
| Ptushkin, VV | 1 |
| Gomez, L | 1 |
| Garau, J | 1 |
| Estrada, C | 1 |
| Marquez, M | 1 |
| Dalmau, D | 1 |
| Xercavins, M | 1 |
| Martí, JM | 1 |
| Estany, C | 1 |
| Bodey, GP | 2 |
| Rolston, KV | 3 |
| Raad, II | 1 |
| Linkin, DR | 1 |
| Fishman, N | 1 |
| Paganini, H | 3 |
| Gómez, S | 1 |
| Ruvinsky, S | 1 |
| Zubizarreta, P | 3 |
| Latella, A | 2 |
| Fraquelli, L | 1 |
| Iturres, AS | 1 |
| Casimir, L | 2 |
| Debbag, R | 2 |
| Prabhu, RM | 1 |
| Elliott, MA | 1 |
| Patel, R | 1 |
| Cometta, A | 2 |
| Kern, W | 2 |
| Niho, S | 1 |
| Ohe, Y | 1 |
| Goto, K | 1 |
| Ohmatsu, H | 1 |
| Matsumoto, T | 1 |
| Kubota, K | 1 |
| Kakinuma, R | 1 |
| Nishiwaki, Y | 1 |
| Escalante, CP | 1 |
| Weiser, MA | 1 |
| Manzullo, E | 2 |
| Benjamin, R | 1 |
| Rivera, E | 1 |
| Lam, T | 1 |
| Ho, V | 1 |
| Valdres, R | 1 |
| Lee, EL | 1 |
| Badrina, N | 1 |
| Fernandez, S | 1 |
| DeJesus, Y | 1 |
| Rolston, K | 2 |
| Lalami, Y | 1 |
| Munoz-Bermeo, R | 1 |
| Reuss, K | 1 |
| Cherifi, S | 1 |
| Alexopoulos, CG | 1 |
| Klastersky, J | 1 |
| Rókusz, L | 1 |
| László, L | 1 |
| Paul, M | 2 |
| Leibovici, L | 2 |
| Bliziotis, IA | 1 |
| Michalopoulos, A | 1 |
| Kasiakou, SK | 1 |
| Samonis, G | 1 |
| Christodoulou, C | 1 |
| Chrysanthopoulou, S | 1 |
| Falagas, ME | 1 |
| Timmer-Bonte, JN | 1 |
| de Boo, TM | 1 |
| Smit, HJ | 1 |
| Biesma, B | 1 |
| Wilschut, FA | 1 |
| Cheragwandi, SA | 1 |
| Termeer, A | 1 |
| Hensing, CA | 1 |
| Akkermans, J | 1 |
| Adang, EM | 1 |
| Bootsma, GP | 1 |
| Tjan-Heijnen, VC | 2 |
| Mizuno, T | 1 |
| Katsumata, N | 1 |
| Mukai, H | 1 |
| Shimizu, C | 1 |
| Ando, M | 1 |
| Watanabe, T | 1 |
| Matsuoka, H | 1 |
| Tsukamoto, A | 1 |
| Shirahashi, A | 1 |
| Koga, S | 1 |
| Suzushima, H | 1 |
| Shibata, K | 1 |
| Uozumi, K | 1 |
| Yamashita, K | 1 |
| Okamura, S | 1 |
| Kawano, F | 1 |
| Tamura, K | 1 |
| Cullen, M | 1 |
| Bucaneve, G | 3 |
| Gafter-Gvili, A | 1 |
| Fraser, A | 1 |
| Patel, SM | 1 |
| Saravolatz, LD | 1 |
| Timmers, GJ | 1 |
| Simoons-Smit, AM | 1 |
| Leidekker, ME | 1 |
| Janssen, JJ | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Huijgens, PC | 1 |
| Sipsas, NV | 1 |
| Kosmas, C | 1 |
| Ziakas, PD | 1 |
| Karabelis, A | 1 |
| Vadiaka, M | 1 |
| Skopelitis, E | 1 |
| Kordossis, T | 1 |
| Tsavaris, N | 1 |
| von Minckwitz, G | 1 |
| Kümmel, S | 1 |
| du Bois, A | 1 |
| Eiermann, W | 1 |
| Eidtmann, H | 1 |
| Gerber, B | 1 |
| Hilfrich, J | 1 |
| Huober, J | 1 |
| Costa, SD | 1 |
| Jackisch, C | 1 |
| Grasshoff, ST | 1 |
| Vescia, S | 1 |
| Skacel, T | 1 |
| Loibl, S | 1 |
| Mehta, KM | 1 |
| Kaufmann, M | 1 |
| Elwood, ET | 1 |
| Sommerville, DN | 1 |
| Murray, JD | 1 |
| Carlson, JW | 2 |
| Fowler, JM | 2 |
| Saltzman, AK | 1 |
| Carter, JR | 1 |
| Chen, MD | 1 |
| Mitchell, SK | 2 |
| Dunn, D | 1 |
| Carson, LF | 2 |
| Adcock, LL | 1 |
| Twiggs, LB | 1 |
| Velasco, E | 1 |
| Costa, MA | 1 |
| Martins, CA | 1 |
| van Tiel, FH | 1 |
| Slangen, BF | 1 |
| Schouten, HC | 1 |
| Jacobs, JA | 1 |
| Ketley, NJ | 1 |
| Kelsey, SM | 6 |
| Newland, AC | 6 |
| Stals, FS | 1 |
| vd Bogaard, AE | 1 |
| Bruggeman, CA | 1 |
| Counsell, R | 1 |
| Pratt, J | 1 |
| Williams, MV | 1 |
| Iacone, A | 3 |
| Fioritoni, G | 3 |
| Parruti, G | 1 |
| Betti, S | 2 |
| Quaglietta, AM | 1 |
| Accorsi, P | 1 |
| Dell'Isola, M | 2 |
| Favalli, C | 1 |
| López, A | 1 |
| Soler, JA | 1 |
| Juliá, A | 1 |
| Novo, A | 1 |
| Bueno, J | 1 |
| Gilbert, C | 1 |
| Meisenberg, B | 1 |
| Vredenburgh, J | 1 |
| Ross, M | 1 |
| Hussein, A | 1 |
| Perfect, J | 1 |
| Peters, WP | 1 |
| McWhinney, PH | 2 |
| Patel, S | 1 |
| Whiley, RA | 1 |
| Hardie, JM | 1 |
| Gillespie, SH | 1 |
| Kibbler, CC | 3 |
| Imrie, K | 1 |
| Gold, W | 1 |
| Salit, I | 1 |
| Keating, A | 1 |
| Romulo, RL | 1 |
| Palardy, JE | 3 |
| Opal, SM | 3 |
| Del Favero, A | 3 |
| Menichetti, F | 2 |
| Rubenstein, EB | 2 |
| Benjamin, RS | 1 |
| Loewy, J | 1 |
| Escalante, C | 1 |
| Hughes, P | 1 |
| Moreland, B | 1 |
| Fender, A | 1 |
| Kennedy, K | 1 |
| Lo, WK | 1 |
| Fanci, R | 1 |
| Leoni, F | 1 |
| Bosi, A | 1 |
| Guidi, S | 1 |
| Ciolli, S | 1 |
| Longo, G | 1 |
| Donnini, E | 1 |
| Rossi Ferrini, P | 1 |
| Cornelissen, JJ | 1 |
| Rozenberg-Arska, M | 2 |
| Dekker, AW | 2 |
| Patrick, CC | 1 |
| Freifeld, A | 2 |
| Pizzo, P | 1 |
| Horowitz, HW | 1 |
| Holmgren, D | 1 |
| Seiter, K | 1 |
| Mani, V | 1 |
| Cartwright, K | 1 |
| Dooley, J | 1 |
| Swarbrick, E | 1 |
| Fairclough, P | 1 |
| Oakley, C | 1 |
| Hidalgo, M | 2 |
| Hornedo, J | 2 |
| Lumbreras, C | 2 |
| Trigo, JM | 1 |
| Gómez, C | 1 |
| Perea, S | 2 |
| Ruiz, A | 1 |
| Hitt, R | 1 |
| Cortés-Funes, H | 2 |
| Mayer, AR | 1 |
| Copeland, LJ | 1 |
| Murphy, M | 1 |
| Brown, AE | 1 |
| Sepkowitz, KA | 1 |
| Bernard, EM | 1 |
| Kiehn, TE | 1 |
| Armstrong, D | 1 |
| Vallejo, C | 1 |
| Caballero, MD | 1 |
| García-Sanz, R | 1 |
| Hernández, JM | 1 |
| Vázquez, L | 1 |
| Cañizo, MC | 1 |
| Galende, J | 1 |
| Colino, CI | 1 |
| Gil-Hurlé, A | 1 |
| San Miguel, JF | 1 |
| Marie, JP | 1 |
| Vekhoff, A | 1 |
| Pico, JL | 1 |
| Guy, H | 1 |
| Andremont, A | 1 |
| Richet, H | 1 |
| Griggs, JJ | 1 |
| Blair, EA | 1 |
| Norton, JR | 1 |
| Rowe, JM | 1 |
| Flesher, WR | 1 |
| Betts, RF | 1 |
| Nouwen, JL | 1 |
| van Belkum, A | 1 |
| de Marie, S | 1 |
| Sluijs, J | 1 |
| Wielenga, JJ | 1 |
| Kluytmans, JA | 1 |
| Verbrugh, HA | 1 |
| Jhung, JW | 1 |
| Keith, JC | 1 |
| Parejo, NA | 1 |
| Young, LD | 1 |
| Bhattacharjee, A | 1 |
| Kerr, KG | 1 |
| Armitage, HT | 1 |
| von Eiff, C | 1 |
| Minotti, V | 1 |
| Gentile, G | 1 |
| Iori, AP | 1 |
| Micozzi, A | 2 |
| Cavicchi, F | 1 |
| Barbabietola, G | 1 |
| Landonio, G | 2 |
| Martino, P | 2 |
| Petropoulos, D | 1 |
| Roberts, WM | 1 |
| Rytting, M | 1 |
| Zipf, T | 1 |
| Chan, KW | 1 |
| Culbert, SJ | 1 |
| Danielson, M | 1 |
| Jeha, SS | 1 |
| Kuttesch, JF | 1 |
| Marchigiani, D | 1 |
| Walsh, T | 1 |
| Chanock, S | 1 |
| Lewis, L | 1 |
| Hiemenz, J | 1 |
| Hiemenz, S | 1 |
| Hicks, JE | 1 |
| Gill, V | 1 |
| Steinberg, SM | 1 |
| Pizzo, PA | 1 |
| Antabli, BA | 1 |
| Bross, P | 1 |
| Siegel, RS | 1 |
| Small, CD | 1 |
| Tabbara, IA | 1 |
| Petrilli, AS | 1 |
| Dantas, LS | 1 |
| Campos, MC | 1 |
| Tanaka, C | 1 |
| Ginani, VC | 1 |
| Seber, A | 1 |
| Aquino, VM | 1 |
| Herrera, L | 1 |
| Sandler, ES | 1 |
| Buchanan, GR | 1 |
| Gomez-Martin, C | 1 |
| Solá, C | 1 |
| Valentí, V | 1 |
| Arcediano, A | 1 |
| Rodriguez, M | 1 |
| Salazar, R | 1 |
| Markman, M | 1 |
| Kennedy, A | 1 |
| Webster, K | 1 |
| Peterson, G | 1 |
| Kulp, B | 1 |
| Belinson, J | 1 |
| Marra, CA | 1 |
| Frighetto, L | 1 |
| Quaia, CB | 1 |
| de Lemos, ML | 1 |
| Warkentin, DI | 1 |
| Marra, F | 1 |
| Jewesson, PJ | 1 |
| Rocchetta, HL | 1 |
| Boylan, CJ | 1 |
| Foley, JW | 1 |
| Iversen, PW | 1 |
| LeTourneau, DL | 1 |
| McMillian, CL | 1 |
| Contag, PR | 1 |
| Jenkins, DE | 1 |
| Parr, TR | 1 |
| Delarive, P | 1 |
| Baumgartner, JD | 1 |
| Glauser, MP | 1 |
| Persson, L | 1 |
| Vikerfors, T | 1 |
| Sjöberg, L | 1 |
| Engervall, P | 1 |
| Tidefelt, U | 1 |
| Rodriguez-Brieshcke, T | 1 |
| Firpo, V | 1 |
| Armada, A | 1 |
| Fernández, C | 1 |
| Cáceres, E | 1 |
| Orlando, R | 1 |
| Mastrullo, L | 1 |
| De Blasi, D | 1 |
| Boffa, ML | 1 |
| Zorzato, G | 1 |
| Miraglia, E | 1 |
| Zaidi, Y | 1 |
| Hastings, M | 1 |
| Murray, J | 1 |
| Hassan, R | 1 |
| Kurshid, M | 1 |
| Mahendra, P | 1 |
| Prentice, HG | 1 |
| Hann, IM | 1 |
| Nazareth, B | 1 |
| Paterson, P | 1 |
| Bhamra, A | 1 |
| Bunn, PA | 1 |
| Postmus, PE | 1 |
| Ardizzoni, A | 1 |
| Lee, DG | 1 |
| Choi, SM | 1 |
| Choi, JH | 1 |
| Yoo, JH | 1 |
| Park, YH | 1 |
| Kim, YJ | 1 |
| Lee, S | 1 |
| Min, CK | 1 |
| Kim, HJ | 1 |
| Kim, DW | 1 |
| Lee, JW | 1 |
| Min, WS | 1 |
| Shin, WS | 1 |
| Kim, CC | 1 |
| Weinhardt, B | 1 |
| Collins, PW | 2 |
| Johnson, PR | 2 |
| Liu Yin, JA | 1 |
| Tooth, JA | 2 |
| Samuelsson, J | 1 |
| Nilsson, PG | 1 |
| Wahlin, A | 1 |
| Lerner, R | 1 |
| Winqvist, I | 1 |
| Palmblad, J | 1 |
| Pizzigallo, E | 1 |
| Piergallini, A | 1 |
| Di Gianfilippo, R | 1 |
| Olioso, P | 1 |
| Torlontano, G | 1 |
| Broughton, BJ | 1 |
| Drusano, GL | 1 |
| Wimperis, JZ | 2 |
| Baglin, TP | 2 |
| Marcus, RE | 1 |
| Warren, RE | 2 |
| Hyatt, DS | 1 |
| Rogers, TR | 1 |
| McCarthy, DM | 1 |
| Samson, DS | 1 |
| Collins, MS | 1 |
| Ladehoff, D | 1 |
| Mehton, NS | 1 |
| Di Girolamo, A | 1 |
| Cellini, L | 1 |
| Nicoletti, M | 1 |
| Villanueva Marcos, JL | 1 |
| Villar Ráez, A | 1 |
| Kindelán Jaquotot, JM | 1 |
| Jurado Jiménez, R | 1 |
| Pons, M | 1 |
| del Blanco, J | 1 |
| Mateo, L | 1 |
| Juanola, X | 1 |
| Beskid, G | 1 |
| Siebelist, J | 1 |
| McGarry, CM | 1 |
| Cleeland, R | 1 |
| Chan, K | 1 |
| Keith, DD | 1 |
| Maschmeyer, G | 1 |
| Daenen, S | 1 |
| de Pauw, BE | 1 |
| de Vries-Hospers, HG | 1 |
| Donnelly, JP | 1 |
| Gaus, W | 1 |
| Haralambie, E | 1 |
| Konrad, H | 1 |
| Moriuchi, Y | 1 |
| Kamihira, S | 1 |
| Yamamura, M | 1 |
| Mori, H | 1 |
| Miyazaki, Y | 1 |
| Tokunaga, S | 1 |
| Nonaka, H | 1 |
| Amagasaki, T | 1 |
| Yamada, Y | 1 |
| Yoshida, Y | 1 |
| Cross, AS | 1 |
| Kelly, NM | 1 |
| Sadoff, JC | 1 |
| Bodmer, MW | 1 |
| Victor, GH | 1 |
| Lewin, CS | 1 |
| Paton, R | 1 |
| Amyes, SG | 1 |
| Delord, C | 1 |
| Weinhard, B | 1 |
| Lim, SH | 1 |
| Smith, MP | 1 |
| Goldstone, AH | 1 |
| Machin, SJ | 1 |
| Wood, ME | 2 |
| Shaw, E | 2 |
| Jenkins, GC | 1 |
| Arning, M | 1 |
| Wolf, HH | 1 |
| Aul, C | 1 |
| Heyll, A | 1 |
| Scharf, RE | 1 |
| Scheider, W | 1 |
| Yin, JA | 1 |
| Constantine, CE | 1 |
| Marcus, R | 1 |
| Philpott-Howard, JN | 1 |
| Barker, KF | 1 |
| Wade, JJ | 1 |
| Kaczmarski, RS | 1 |
| Smedley, JC | 1 |
| Mufti, GJ | 1 |
| Kotilainen, P | 1 |
| Nikoskelainen, J | 1 |
| Huovinen, P | 1 |
| Oppenheim, BA | 2 |
| Hartley, JW | 1 |
| Lee, W | 1 |
| Burnie, JP | 1 |
| Minetti, B | 1 |
| Ricci, P | 1 |
| Montillo, M | 1 |
| Malleo, C | 1 |
| Chan, CC | 1 |
| Anderson, H | 1 |
| Swindell, R | 1 |
| Scarffe, JH | 1 |
| Obana, Y | 1 |
| Nishino, T | 1 |
| Bayston, KF | 1 |
| Want, S | 1 |
| Cohen, J | 1 |
| Flaherty, JP | 1 |
| Waitley, D | 1 |
| Edlin, B | 1 |
| George, D | 1 |
| Arnow, P | 1 |
| O'Keefe, P | 1 |
| Weinstein, RA | 1 |
| Patton, WN | 1 |
| Smith, GM | 3 |
| Leyland, MJ | 3 |
| Geddes, AM | 3 |
| Chin, NX | 1 |
| Jules, K | 1 |
| Neu, HC | 1 |
| Bendig, JW | 1 |
| Kyle, PW | 1 |
| Giangrande, PL | 1 |
| Samson, DM | 1 |
| Azadian, BS | 1 |
| Verhoef, J | 1 |
| Dekker, A | 1 |
| Peterson, LR | 1 |
| Moody, JA | 1 |
| Fasching, CE | 1 |
| Gerding, DN | 1 |
| Mannan, P | 1 |
| Noone, P | 1 |
| Gordin, FM | 1 |
| Hackbarth, CJ | 1 |
| Scott, KG | 1 |
| Sande, MA | 1 |
| Trautmann, M | 1 |
| Brückner, O | 1 |
| Marre, R | 1 |
| Hahn, H | 1 |
| Farrell, ID | 2 |
| Fu, KP | 1 |
| Hetzel, N | 1 |
| Gregory, FJ | 1 |
| Hung, PP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Feasibility Study of the Use of Intermediate Doses of Cytarabine Associated With Autologous Hematopoietic Stem Cells as Consolidation Treatment of Young Adults With Low- or Intermediate-risk de Novo Acute Myeloid Leukemia[NCT03023384] | 547 participants (Anticipated) | Observational [Patient Registry] | 2016-12-31 | Recruiting | |||
| A Prospective Multi-Center Study on Pediatric Patients With Fever in Severe Chemotherapy Induced Neutropenia, Including a Randomized Comparison of Outpatient Management and Oral Antimicrobial Therapy Versus Inpatient Management and Intravenous Antimicrobi[NCT00107081] | Phase 3 | 70 participants (Actual) | Interventional | 2004-01-31 | Terminated (stopped due to Accrual goal for interventional part not achievable) | ||
| Randomized Controlled Trial Comparing Ciprofloxacin With Cefepime in Febrile Neutropenic Patients With Hematologic Diseases[NCT00137787] | Phase 3 | 51 participants (Actual) | Interventional | 2005-04-30 | Completed | ||
| Oral Empirical Therapy of Fever in Low-Risk Neutropenic Cancer Patients: A Prospective, Double-Blind, Randomized, Multicenter Trial Comparing Monotherapy (Single Daily Dose Moxifloxacin) With Combination Therapy (Ciprofloxacin Plus Amoxicillin/Clavulanic [NCT00062231] | 351 participants (Actual) | Interventional | 2002-04-30 | Terminated (stopped due to low accrual) | |||
| Intermittent Every Other Days of 5 Shot-filgrastim Compared With Single Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide Chemotherapy (Intermittent G-CSF 105)[NCT02685111] | Phase 2 | 22 participants (Actual) | Interventional | 2016-02-29 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for ciprofloxacin and Neutropenia
| Article | Year |
|---|---|
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement.
Topics: Cause of Death; Ciprofloxacin; Contraindications; Delayed-Action Preparations; Disease Progression; | 2015 |
[Treatment and prevention of infections in cancer patients with neutropenia].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Bacterial In | 2011 |
Ecthyma gangrenosum: considerations in a previously healthy child.
Topics: Administration, Oral; Chronic Disease; Ciprofloxacin; Ecthyma; Female; Follow-Up Studies; Granulocyt | 2002 |
Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacterial I | 2003 |
[Treatment with oral antibiotics of febrile neutropenia in onco-haematology. The experience of the EORTC antimicrobial group].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Ceftazidi | 2004 |
Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Feve | 2005 |
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciproflox | 2006 |
Monotherapy versus combination therapy.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cellulit | 2006 |
Ciprofloxacin-induced nephrotoxicity in patients with cancer.
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Female; Fever; Humans; Kidney; Male; Middle Aged; Neoplasm | 1993 |
Prevention of infection in acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; In | 1990 |
Prevention of infection by ciprofloxacin in neutropenia.
Topics: Ciprofloxacin; Erythromycin; Feces; Gram-Negative Bacteria; Humans; Neutropenia; Sepsis; Staphylococ | 1990 |
61 trials available for ciprofloxacin and Neutropenia
| Article | Year |
|---|---|
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; An | 2020 |
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Ceftriaxo | 2008 |
[Equalization of breast cancer chemotherapy at general hospital( II )-evaluation of safety in FEC and TC regimens].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Ciprofloxa | 2009 |
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Fever; Graft Survival; Hematologic Neo | 2010 |
First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Antineoplasti | 2012 |
Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agen | 2013 |
Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; | 2013 |
Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectiou
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Ag | 2013 |
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; | 2013 |
Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplant | 2002 |
Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Topics: Administration, Oral; Ambulatory Care; Amoxicillin; Antineoplastic Agents; Blood Cell Count; Child; | 2003 |
[Benzylpenicillin efficacy for neutropenic infection prophylaxis in patients with cancer and postcytostatic neutropenia].
Topics: Adolescent; Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial I | 2002 |
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Antineoplastic A | 2003 |
Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
Topics: Administration, Oral; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ce | 2004 |
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Ampicillin; Anti-Bacterial Agents; Cancer Care Facilities; | 2004 |
A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Age | 2004 |
Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combin | 2005 |
Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
Topics: Adult; Aged; Algorithms; Carbapenems; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hemato | 2006 |
Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cross Infecti | 2007 |
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ciprofloxacin; Cyclop | 2008 |
Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
Topics: Administration, Oral; Adult; Amikacin; Carbenicillin; Ceftazidime; Ciprofloxacin; Costs and Cost Ana | 1995 |
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
Topics: Adult; Aged; Agranulocytosis; Anti-Infective Agents; Bacteremia; Bacterial Infections; Ciprofloxacin | 1994 |
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; B | 1994 |
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Aztreonam; Bacteremia; Bacterial Inf | 1993 |
Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amoxicillin; Bacteria; Bacterial Infections; Ciprofloxacin | 1993 |
Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fever of Unknown | 1995 |
Stepdown single agent antibiotic therapy for the management of the high risk neutropenic adult with hematologic malignancies.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciproflo | 1996 |
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antineoplastic Com | 1997 |
Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Bacteri | 1997 |
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combinati | 1998 |
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
Topics: Adult; Amphotericin B; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever | 1998 |
Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; C | 1999 |
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Topics: Adolescent; Ambulatory Care; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporin | 1999 |
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Ag | 1999 |
Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bone Marrow Transplantation; C | 1999 |
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Anti-Infective Agents; Antineoplastic Agen | 2000 |
Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antineoplastic Age | 2000 |
A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Costs and Cost Analysis; Female; | 2000 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineopla | 2001 |
Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Bacterial Infections; Bone Marrow Transplantation; | 2001 |
Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Drug Ther | 2002 |
Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.
Topics: Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fever; Gentamicins; Glycopeptides; H | 1992 |
A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Azlocillin; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; | 1992 |
A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients.
Topics: Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gra | 1991 |
Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients.
Topics: Adult; Aged; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Female; Gram-Negative Bacteria; G | 1991 |
Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Female; Fever; | 1991 |
Prevention of infection in acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; In | 1990 |
[Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].
Topics: Administration, Inhalation; Administration, Oral; Bacterial Infections; Ciprofloxacin; Drug Administ | 1990 |
Assessment of the interaction between ciprofloxacin and teicoplanin in vitro and in neutropenic patients.
Topics: Adult; Ciprofloxacin; Drug Therapy, Combination; Glycopeptides; Humans; Methicillin Resistance; Midd | 1990 |
A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; D | 1990 |
A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.
Topics: Anti-Bacterial Agents; Bacteria; Catheterization, Peripheral; Ceftazidime; Ciprofloxacin; Drug Thera | 1990 |
A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Injections, In | 1990 |
Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
Topics: Bacterial Infections; Ciprofloxacin; Colistin; Humans; Neutropenia; Ofloxacin; Precursor Cell Lympho | 1990 |
High dose intravenous ciprofloxacin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ciprofloxacin; Female; Fever; Gram-Negative Bacteria; | 1990 |
Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Azlocillin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Femal | 1990 |
[Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)].
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Bone Marrow Transplantation; Ciproflox | 1989 |
Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fe | 1989 |
Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Bone Marrow Tr | 1989 |
A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever.
Topics: Adolescent; Adult; Agranulocytosis; Bacterial Infections; Ceftazidime; Ciprofloxacin; Female; Fever; | 1989 |
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazi | 1989 |
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug | 1987 |
86 other studies available for ciprofloxacin and Neutropenia
| Article | Year |
|---|---|
Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Clostridioides difficile; | 2017 |
Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services.
Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Child; Child, Preschool; | 2017 |
Ciprofloxacin prophylaxis in children with acute leukemia in an era of increasing antibiotic resistance.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ciprofloxacin; Female; Fever; Humans; Male; Neutropeni | 2013 |
Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremi | 2013 |
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Bacteria; Bacterial Infections; Ciprofloxacin; Fema | 2013 |
Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.
Topics: Adolescent; Aged; Antibiotic Prophylaxis; Ciprofloxacin; Female; Fever; Humans; Incidence; Induction | 2016 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Chil | 2014 |
Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drugs, Generic; Mice; Microbial Sensitivity Tests; Ne | 2015 |
Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infecti | 2015 |
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillu | 2016 |
A Child With Septic Shock and Purpura.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Female; Hu | 2016 |
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineopl | 2016 |
Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antilymphocyte Serum; Bacteremia; Child; | 2017 |
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced | 2009 |
Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin.
Topics: Administration, Oral; Adult; Agranulocytosis; Anti-Bacterial Agents; Anti-Infective Agents; Ciproflo | 2009 |
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ciprofloxacin; Daptomycin; Ente | 2010 |
[Oral antibiotics for non-Hodgkin's lymphoma patients with low risk neutropenic fever--a comparative controlled study].
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Agents; Ciprofloxacin; Clav | 2010 |
"Good enough" medicine: noninferiority clinical trials and the management of fever and neutropenia.
Topics: Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Femal | 2012 |
Outpatient therapy for fever and neutropenia is safe but implementation is the key.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Female; Fev | 2013 |
Summaries for patients. Treatment of fever in hospitalized patients with low white blood cell counts.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplant | 2002 |
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic F | 2002 |
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Neutropenia | 2002 |
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Cefepime; Cephalosporins; Ciprofloxacin; Clarithromycin; Da | 2002 |
Pasteurella multocida infection in a post-chemotherapy neutropenic host following cat exposure.
Topics: Aged; Animals; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplas | 2002 |
Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin | 2003 |
Ciprofloxacin versus tobramycin for neutropenic fevers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Fever; Human | 2003 |
Ciprofloxacin versus tobramycin for neutropenic fevers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Fever; Human | 2003 |
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Female; Fluoroquinolones; Hematopoi | 2004 |
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Topics: Anti-Bacterial Agents; Argentina; Ceftriaxone; Child; Ciprofloxacin; Humans; Neoplasms; Neutropenia; | 2004 |
Infections of febrile neutropenic patients in malignant hematological diseases (second study period).
Topics: Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Bacterial Infections; Ciprofloxacin; Fema | 2005 |
Systematic reviews and meta-analysis of febrile neutropenia.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Feve | 2005 |
The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.
Topics: Adult; Aged; Ambulatory Care; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; | 2007 |
Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; A | 2007 |
Periorbital necrotizing fasciitis.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Breast Neoplasms; | 2007 |
Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
Topics: Administration, Oral; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bacteria | 1994 |
Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cluster Analysis; Colony Count, Microbial; Cross Infection; Dr | 1995 |
Teicoplanin and oral ciprofloxacin as outpatient treatment of infective episodes in patients with indwelling central venous catheters and haematological malignancy.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Bacterial Infections; Catheterization, Cen | 1995 |
Prevention of bacteraemia by systemic ciprofloxacin treatment in rat cytomegalovirus-infected immunocompromised rats.
Topics: Animals; Bacteremia; Ciprofloxacin; Cytomegalovirus Infections; Gram-Negative Aerobic Bacteria; Gram | 1994 |
Chemotherapy for germ cell tumours: prophylactic ciprofloxacin reduces the incidence of neutropenic fever.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carbo | 1994 |
[Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
Topics: Adult; Aged; Bacterial Infections; Ciprofloxacin; Female; Humans; Leukemia, Myeloid, Acute; Male; Mi | 1994 |
Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Humans; Microbial | 1993 |
Ciprofloxacin-induced neutropenia and erythema multiforme.
Topics: Aged; Ciprofloxacin; Erythema Multiforme; Female; Humans; Neutropenia; Respiratory Tract Infections | 1993 |
Efficacy of anti-endotoxin monoclonal antibody E5 alone or in combination with ciprofloxacin in neutropenic rats with Pseudomonas sepsis.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Endotoxins; F | 1993 |
The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Gram-Negativ | 1993 |
Use of fluoroquinolones as prophylactic agents in patients with neutropenia.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Digestive System | 1997 |
Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients.
Topics: Administration, Oral; Anti-Infective Agents; Child; Ciprofloxacin; Fever of Unknown Origin; Humans; | 1997 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophyla | 1997 |
Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Therapy; Ent | 1997 |
Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Analysis of Variance; | 1997 |
Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hemato-oncologic department.
Topics: Air Microbiology; Antibiotic Prophylaxis; Bacteriological Techniques; Catheterization, Central Venou | 1998 |
Recombinant human interleukin-11 in experimental Pseudomonas aeruginosa sepsis in immunocompromised animals.
Topics: Animals; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Com | 1998 |
Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy.
Topics: Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Hematologic N | 1999 |
In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Human | 1998 |
Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Anti-Infective Agents; Blood Cell Count; C | 2000 |
Experience with prophylactic oral ciprofloxacin in gynecological cancer patients developing severe chemotherapy-induced neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocol | 2000 |
Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cell Count; Cephalosporins; Cipr | 2001 |
[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Ciprofloxacin; Dru | 2000 |
Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; | 2000 |
Aeromonas sobria sepsis in a neutropenic patient.
Topics: Acute Disease; Aeromonas; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxaci | 2001 |
Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan.
Topics: Anti-Infective Agents; Bacteremia; Ciprofloxacin; Drug and Narcotic Control; Drug Prescriptions; Dru | 2001 |
Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemot | 2001 |
Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Fever; Humans; Neoplasms; | 2002 |
Reply to the article "Editorial comments on 'reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'", by P.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cipro | 2002 |
A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ciprofloxacin; Drug Therapy, Combination; Dru | 1992 |
Occurrence of bacteremia in hematologic patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Bone Marrow Transplantation; Catheterization; Ciprofloxacin; Fe | 1992 |
Prevention of infection during neutropenia.
Topics: Ciprofloxacin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fluconazole; Huma | 1992 |
Optimal sampling theory and population modelling: application to determination of the influence of the microgravity environment on drug distribution and elimination.
Topics: Bayes Theorem; Ceftazidime; Chromatography, High Pressure Liquid; Ciprofloxacin; Cystic Fibrosis; Fe | 1991 |
An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts.
Topics: Adolescent; Adult; Amphotericin B; Bacteremia; Bacterial Infections; Bone Marrow Transplantation; Ci | 1991 |
Therapy of established experimental Pseudomonas aeruginosa infections with oral ciprofloxacin and five human monoclonal antibodies against lipopolysaccharide antigens.
Topics: Animals; Antibodies, Monoclonal; Antigens, Bacterial; Burns; Cellulitis; Ciprofloxacin; Immunotherap | 1991 |
[Neutropenia caused by ciprofloxacin and Escherichia coli bacteremia. Bone marrow examination].
Topics: Bacteremia; Bone Marrow Examination; Ciprofloxacin; Escherichia coli Infections; Humans; Neutropenia | 1991 |
[Ciprofloxacin-induced neutropenia: an infrequent adverse effect].
Topics: Aged; Ciprofloxacin; Humans; Male; Neutropenia; Spondylitis | 1991 |
In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Cefotaxime; Ciprofloxacin; Drug Evaluation, Pr | 1990 |
Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.
Topics: Agranulocytosis; Animals; Antibodies, Monoclonal; Ciprofloxacin; Combined Modality Therapy; Disease | 1990 |
Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.
Topics: Aged; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Female; Humans; Immune Tolerance; Leukem | 1990 |
Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit.
Topics: Cancer Care Facilities; Ciprofloxacin; Coagulase; Cross Infection; Disease Outbreaks; Drug Resistanc | 1989 |
In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Mice; Microbial | 1989 |
Multiply resistant Salmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Drug Resistance, Microbial; Hu | 1985 |
Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
Topics: Animals; Azlocillin; Bacteria; Carbenicillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combinati | 1986 |
Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.
Topics: Adolescent; Aged; Agranulocytosis; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; | 1987 |
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, | 1987 |
Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxis.
Topics: Agranulocytosis; Ciprofloxacin; Colistin; Drug Resistance, Microbial; Humans; Microbial Sensitivity | 1988 |
Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Ciprofloxacin; Guinea Pigs; Half-Life; Microbial Se | 1985 |
Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice.
Topics: Agranulocytosis; Animals; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combinat | 1988 |
A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; L | 1988 |
Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Female; Fever; Half-Life; Humans; | 1986 |
Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
Topics: Agranulocytosis; Animals; Cephalosporins; Ciprofloxacin; Cyclophosphamide; Drug Therapy, Combination | 1987 |